Trial NCT02237183

Iloprost in Preventing Lung Cancer in Former Smokers

This phase I trial studies the side effects and best dose of iloprost compared with a placebo in preventing lung cancer in former smokers. Chemoprevention is the use of drugs to keep cancer from forming or coming back. Inhaled iloprost may help prevent lung cancer from forming in patients who used to smoke and who have been found to have abnormal cells in their mucus.

Intervention

Placebo Administration, Iloprost, Quality-of-Life Assessment, Questionnaire Administration

Condition

Cytologic Atypia, Former Smoker, Mild Dysplasia

Investigators

See list of participating sites